Chicago Atlantic Real Estate Finance, Inc. (REFI) Earnings Call Transcript & Summary
November 10, 2026
Earnings Call Speaker Segments
Lisa Kampf
executiveThanks. Morning, everyone, and welcome to the Chicago Atlantic Real Estate Finance conference call, where we'll go over the company's results. Joining us today are Peter Sack, Co-Chief Executive Officer; David Kite, President and Chief Operating Officer; and Phil Silverman, Chief Financial Officer. We put out our results this morning in the earnings press release, which you can find in the Investor Relations section of our website together with our earnings supplemental — both of which have been furnished to and filed with the SEC. A live audio webcast of today's call is available. If you're listening to the replay of this webcast, please note that what we say here reflects today only and won't be updated after this call. Certain remarks and comments on today's call could be classified as forward-looking statements as defined by securities laws. That covers things like what we expect from how our portfolio performs going forward, our pipeline of possible loans and other investments, upcoming dividends, financing efforts, the proposed combination of the company with Chicago Atlantic BDC, Inc., ticker LIEN, and when that deal is expected to close and what benefits it should bring. We also touch on certain non-GAAP measures, among them distributable earnings but not limited to that figure. Definitions for these non-GAAP measures, plus reconciliations to the closest comparable GAAP measures, appear in our earnings release and supplemental information, both of which you can find on our website and which have been furnished to the SEC. Just a quick note before we go further: what I say today, along with the earnings supplemental, contains forward-looking statements. Those carry meaningful risks and uncertainties, and because of them actual results may end up materially different from what we currently expect. We encourage investors to take a close look at the different disclosures the company has issued — this includes the risks and other details found in our filings with the SEC. The risks and uncertainties cover whether REFI and LIEN can finish their merger within the expected timeframe; whether they can secure the necessary stockholder approvals from both companies, including from their affiliated stockholders, along with the post-BDC election approvals and any required third-party consents; the possibility that REFI chooses BDC regulation while the merger never closes; conflicts of interest stemming from the company's advisors' affiliation; shifts in the exchange ratio; whether the transaction's anticipated benefits will actually be achieved; and developments affecting the cannabis regulatory landscape; plus the additional risks outlined in our SEC filings and in the legends contained in the materials filed today. Real outcomes could vary significantly, and unless the law mandates it, we’re not committing to any updates. This call’s transcript will go to the SEC under Rule 425 of the Securities Act of 1933 and is considered filed under Rule 14a-12 of the Securities Act of 1934. Regarding the planned merger, LIEN has submitted to the SEC an amended registration statement on Form N-14, containing a preliminary joint proxy statement from REFI and LIEN plus a preliminary LIEN prospectus. That registration statement has not yet been declared effective. Stockholders and investors should review those documents — the definitive joint proxy statement/prospectus once it's filed, along with any amendments or supplements — since they hold or will hold key details regarding the transaction. LIEN, REFI, each of their respective directors and executive officers, Chicago Atlantic BDC Advisers, LLC, and Chicago Atlantic REIT Manager, LLC, plus certain other individuals, might be considered participants in the solicitation. Details concerning those individuals and their interests appear in the preliminary joint proxy statement/prospectus. All filed materials can be obtained at no cost through the SEC's website and each company's Investor Relations website. Keep in mind that nothing said on this call is an offer to sell or a solicitation of an offer to buy any securities. Securities offers will only be made by means of a prospectus satisfying Section 10 of the 1933 Act. I'll hand the call to Peter Sack now. Please go ahead.
Peter Sack
executiveThanks, Lisa, and good morning, everyone. During the quarter, we kept our attention on the priorities that shape our strategy: originating strong loans, maintaining disciplined underwriting standards, and actively managing the portfolio we already hold so we can generate appealing risk-adjusted returns for shareholders. As I've noted previously, Chicago Atlantic Real Estate Finance occupies a distinctive intersection of real estate, credit, and the U.S. cannabis industry, and it has very little overlap with the broader mortgage REIT and credit markets. By focusing on one sector, we can develop deep expertise in loan origination, underwriting, and real estate analytics. Those capabilities distinguish us from other lenders in the industry. The combination of our niche expertise, long-standing relationships, and thorough grasp of risk allows us to put together investments with a depth of insight that larger, more general lenders frequently cannot match. I want to spend a few moments comparing Chicago Atlantic Real Estate Finance, Inc. with the wider mortgage REIT sector as of September 30th, 2026. From where we sit, how REFI's borrowers perform has minimal connection to the wider residential and commercial mortgage real estate markets. As far as we are aware, no borrower in REFI's portfolio overlaps with those of any other publicly traded mortgage REIT. About 57% of the portfolio stands to gain when rates go up, and because none of our loans have interest rate caps, each 25 basis point move higher should translate into a 1.5 cents per share gain in quarterly distributable earnings. On an unlevered basis, REFI's weighted average portfolio yield was around 14.8%, compared with about 6% to 8% for select commercial mortgage REIT peers on a comparable basis. REFI's leverage sits at 0.48 times debt to equity, while that same peer group runs roughly 3 to 5x total debt to stockholder equity. REFI doesn't hold any residential mortgage-backed securities, commercial mortgage-backed securities, or agency securities. Rather, it acts as an agent and originates almost all of its portfolio directly, investing at low leverage levels, using strong documentation with covenants, and gaining direct insight into how its borrowers operate. In our view, REFI's portfolio and operating model stand apart considerably from the wider mortgage REIT market. Despite that, REFI's share price has recently traded in close step with the broader mortgage REIT market. From the start of the year through November 6th, 2026, REFI and the VanEck Mortgage REIT Income ETF, ticker MORT, each posted total returns of roughly negative 17% to 18%. Also, in September, the 10-year Treasury yield climbed by about 54 basis points. After the Fed's 25 basis point rate hike on September 17th, the share prices of REFI and MORT both fell in line by about 9% through September 30th, even though rising interest rates actually benefit REFI's net interest income. As I've noted before, I believe REFI has not been rewarded for its differentiation from the mortgage REIT market. Some mortgage REIT investors may conclude that REFI is simply too small for them — that underwriting a meaningful position in REFI isn't worth the time and effort, especially given the learning curve involved in grasping our industry. Turning to a different topic, when the Special Committee and the Board evaluated the proposed merger with Chicago Atlantic BDC, Inc., or LIEN, they took into account that the cannabis-focused mortgage REIT model carries structural constraints that could, over time, limit REFI's capacity to build shareholder value; among those constraints are REFI's comparatively small scale, the restrictions our REIT election imposes on our investment mandate, and a limited ability to obtain institutional debt capital and to widen our investor base. They further took into account that our cannabis-only mandate has kept institutional investors from participating in REFI common stock. Back in June, after the Special Committee gave its unanimous recommendation, the Board signed off on three things: the merger agreement with LIEN, REFI's choice to be regulated as a BDC, and the merger itself — and stockholder approval is still needed for each one. Although REFI's assets are secured by real estate, they look a lot like a BDC's, since REFI lends to operating businesses; on top of that, the investment strategies and management teams at REFI and LIEN are substantially similar. The Special Committee and the Board took into account that the combined company would possess greater scale and a broader investment mandate capable of providing diversification across borrowers, sectors, and collateral types; they also took into account that its trading liquidity might increase, widening the universe of potential investors, and that it might draw additional institutional investor interest over time, though no assurance can be given that this will occur. For these reasons, among others, I back the Board's recommendation regarding the REFI and LIEN merger. The Special Committee and the Board weighed several considerations — including what could go wrong with the deal and how REFI's directors, officers, and manager stand to gain from the merger, which might not line up with what stockholders generally want. All of that is laid out in the joint proxy statement and prospectus, and we encourage stockholders to give it a read. I'll let David and Phil, my colleagues, speak to performance, but I did want to offer the team my congratulations on a busy quarter. During the period, we put to work over $85 million in fresh principal fundings, expanded the capacity of our revolving credit facility, finished the Koch deal, posted 49 cents of adjusted distributable earnings per fully diluted share, and declared a regular quarterly dividend of 47 cents per share — marking the 18th quarter in a row we have done so. The Koch transaction wrapped up in July, when REFI issued roughly 4.3 million new common shares priced at $14.353 each in return for second-lien notes carrying an aggregate principal balance of $62.6 million; we call these instruments the Koch notes throughout our remarks. In Q3, a Florida property sale led to the full repayment of one of the 32 Koch notes, which brought in fee income of roughly $900,000. In total, the Koch notes contributed about $2.6 million to distributable earnings in the third quarter, and we remain hopeful that this transaction will continue to deliver an attractive yield. The Koch portfolio has a stated annual yield of approximately 12%, which lowers the weighted average yield for REFI's portfolio overall. Even with that, the Koch notes generated an annualized return of more than 18% this quarter, which adds to our portfolio yield. I'd invite you to look over the slides covering the Koch notes and the case study on Koch's property sale during the quarter, both of which are in our earnings supplemental. To wrap up, we've kept executing deliberately while making strategic choices that strengthen REFI and put the company in position for long-term success to the benefit of shareholders. We're still confident in our capacity to steer through a volatile economic landscape while remaining disciplined in our underwriting and faithful to the strategy that has produced our results so far; we look forward to the REFI and LIEN stockholder meetings and, should the merger be approved and completed, to carrying on with our strategy as part of the combined company. David will now walk you through the portfolio in more detail. David?
David Kite
executiveThanks, Peter. At September 30th, the aggregate principal amount across our loan portfolio — covering loans held for investment, loans at fair value, and the Koch notes shown within stockholders' equity under GAAP — came to roughly $527.7 million, spread over 28 portfolio companies, with a weighted average yield to maturity of 14.8%. For the quarter, gross originations were about $85.1 million in principal fundings; of that, $17.5 million went to new borrowers, $5 million to existing borrowers, and $62.6 million came from the Koch transactions. Offsetting those fundings were repayments of roughly $13.2 million, made up of about $3.8 million in scheduled amortization, $7 million in full loan prepayments, and $2.4 million in partial prepayments. Portfolio risk ratings and credit quality were fairly stable in Q3, with 89.3% rated 3 and below, while 10.7% of the portfolio carries a risk rating of 4 or 5. At September 30th, 2026, non-accruals were unchanged in amount from June 30th and represented about 3.1% of the total loan portfolio on an outstanding principal basis, versus roughly 3.7% at June 30th, 2026 — the decline mainly reflecting growth in portfolio size. As of September 30th, 2026, the portfolio was 36% fixed-rate loans and 64% floating-rate loans. Of the floating-rate loans, approximately 69.2% are benchmarked to prime and 30.8% to SOFR. With prime currently at 7%, 73% of our prime-rate loans sit at their floors and turn accretive once rates exceed 7.2%. Importantly, none of our floating-rate loans carry interest rate caps, and they benefit from rate floors — a structural advantage over most mortgage REITs. Total leverage was 40% of book equity at September 30th, up just 1% from June 30th. At September 30th, we had $94.4 million outstanding on the senior secured revolving credit facility and 59 outstanding on the unsecured term loan. In Q3, additional commitments from our existing bank syndicate raised available borrowing capacity under the revolver by $7.5 million, bringing total availability to $117.5 million. As of today, roughly $15.2 million is available on the senior credit facility, and total liquidity, net of estimated liabilities and anticipated fundings, is about $12 million. After quarter-end, we funded $3.2 million to existing borrowers under fully discretionary delayed draw term loan facilities. We're looking at ways to expand liquidity, but we expect originations to slow in the fourth quarter of 2026. I'll now hand it to Phil.
Phil Silverman
executiveThanks, David. I want to start by restating how the Koch transaction appears in our consolidated financial statements as of and for the period ended September 30th. As we've said before, since the Koch notes came to us as consideration for issuing the company's common stock, they show up as a reduction of stockholders' equity, not as loans held for investment or inside total assets on the consolidated balance sheet. Also, the related cash flows from interest, principal, and exit fees, if any, get classified as financing activities and run through stockholders' equity, instead of being recognized as interest income in the consolidated statement of operations. Turning to third quarter results. Net interest income came in at $12.5 million for the third quarter, down $0.3 million, or 2.3%, from $12.8 million in the second quarter. But if you adjust for cash interest proceeds from the Koch notes, total net interest income was $15.1 million, an increase of roughly 18%. On that adjusted basis, the gain came from about $2.6 million of interest and fee income on the Koch notes, the timing of capital deployments and repayments, and the modest effect of the 25 basis point prime rate increase in mid-September. Those increases were offset by higher interest expense, which went from approximately $2.4 million in Q2 to $2.9 million in Q3, driven by weighted average borrowings on our revolving loan rising from $67.5 million to $95.5 million between the comparative periods. Our CECL reserve on loans held for investment as of September 30th stood at roughly $12.3 million, and relative to size, our reserve for expected credit losses is about 2.9% of the outstanding principal of our loans held for investment. While we don't record CECL reserves on the Koch notes in our consolidated financial statements, we estimate a CECL reserve attributable to the notes of $1.8 million, or approximately 3% of the principal balance. The company's non-accrual positions saw no material changes, and they represent 3.1% of our total portfolio, inclusive of the Koch notes, all of which are current on interest payments. Distributable earnings per weighted average share on a basic and fully diluted basis were approximately 50 cents and 49 cents, respectively. Third quarter distributable earnings include approximately $2.6 million of interest and fees earned on the Koch notes during the quarter, which are excluded from GAAP net income but will be included in REIT taxable income for the 2026 tax year. In October, we distributed the third quarter dividend of 47 cents per common share, which our Board declared in September. Alongside GAAP book value per share, we present adjusted book value per share on an as-paid basis, which is a non-GAAP financial measure. We calculate adjusted book value on an as-paid basis by taking total stockholders' equity under GAAP and adding back the outstanding principal amount of the Koch notes, along with any accrued but unpaid interest on them that GAAP has subtracted from or failed to recognize in stockholders' equity; this metric shows our book value as though the Koch notes had been fully repaid in cash as of the balance sheet date. We think adjusted book value per share on an as-paid basis is helpful for investors, since it mirrors the capital contributed to us through the Koch transaction on the same footing as the shares issued, aligns with how the Koch notes are handled when determining the exchange ratio under the merger agreement, and lets our shareholders compare our book value per share against prior periods and against other commercial mortgage REITs that recognize their loans as assets. As of September 30th, 2026, our adjusted book value per common share outstanding came to $14.12, versus $14.15 as of June 30th. On a fully diluted basis, roughly 26 million and 21.7 million common shares were outstanding as of September 30th and June 30th, respectively. Operator, we're ready for questions now.
Aaron Grey
analystGood morning, and many thanks for that question. Regarding the idea that the need for real estate coverage might shift at any moment following the merger with LIEN, while we keep this within the REFI context, how should we view the pipeline when proper real estate coverage is in place, and how might that potentially change as additional states come online versus there being more opportunities in states that are maturing? Especially if you consider perhaps Georgia, Texas, and Kentucky on the medical side, or other states that could legalize following legislative-level changes in the November 3rd election? Any commentary on that, staying within the confines of just REFI real estate coverage, would be helpful. Thanks.
Peter Sack
executiveSure. Thanks, Aaron. The pipeline was down this quarter, partly on a quarter-over-quarter basis, partly because of the significant amount of fundings we completed this quarter from the pipeline, and second, because our available liquidity as of today is largely used up. Having said that, I'm excited about the opportunities that this month's election results may create. In particular, I think medical states like Pennsylvania, Texas, and Georgia will benefit from Democratic executive leaders in the governor's office, which could lead to expansions of those medical markets, and in Pennsylvania's case, possibly an expansion of bills for adult use. That will create opportunities for both REFI and LIEN and for cannabis investment throughout the space, which we're quite excited about. I don't believe, though, that it alters the long-term thesis we founded in the materials concerning the LIEN-REFI merger, and the belief that a vehicle not constrained by a real estate mandate has a much stronger set of opportunities.
Aaron Grey
analystGreat, great. I appreciate that added color. My second question is really about the higher yields, or higher rates, and what effect that's had across the wider mortgage REIT category. You alluded somewhat to the chance to decouple, to how you might stand apart from other mortgage REITs. Could you expand on that, and why — perhaps not solely on a REFI basis, but also when combined with LIEN — you believe that would paint a clearer picture of how you differ from the broader mortgage REIT space, even in a higher-rate environment? Thanks.
Peter Sack
executiveThank you. During our prepared remarks, we tried to explain what we regard as a contradiction: our view that this portfolio differs sharply from the wider mortgage REIT market when it comes to the actual assets held, the industry and economic fundamentals to which it is exposed, and how rising interest rates affect our portfolio relative to that broader market. Strangely, opposite to that, we presented several data points showing REFI trading essentially in step with the wider mortgage REIT market, and moving alongside that broader market as interest rate increases have materialized. That mismatch, or contradiction, is the thing we intended to point out. When we consider the BDC and the mortgage REIT together as one vehicle, one opportunity it offers, I believe, is to be compared against a different set of comparables. Comparing to the mortgage REIT market isn't necessarily all that relevant, and the goal is that, measured against the BDC and private credit markets, the relative differentiation of these portfolios will become clearer to the investor community, and that BDC investors fundamentally will view it more favorably, with our portfolio appealing more to that community than it perhaps does to the mortgage REIT investor community; in a rising interest rate environment, the effect of rising interest rates is purely arithmetic. Each 25 basis points of interest rate increase produces roughly 1.5 cents per quarter of additional distributable earnings. That's a powerful tool, and it comes from very thoughtful portfolio construction — originating transactions at floating rates with notably high interest rate floors that give REFI investors convexity benefits when interest rates rise without sacrificing income when interest rates fall. Did that cover your points, Aaron?
Aaron Grey
analystThat was excellent. I really appreciate that color. I’ll go and jump back into the queue.
Chris Muller
analystHey, guys. Thanks for taking the questions. I have a couple of questions on the Koch deal, and sorry if I missed some of this in Phil’s comments, but the 231 out of book value from the Koch notes, should that come back into book value over time? Is that correct? Then could there be more upside to that, or does that include the potential exit fees in that number? Hey,
Peter Sack
executiveChris. Go for
Chris Muller
analystit,
Peter Sack
executivePhil.
Phil Silverman
executiveI’ll take that one. Thanks, Chris. Yes, regarding the 231 — that reflects a reduction, and the cause is that we clearly issued roughly 4.3 million shares, but book value is unchanged since the note is entirely offset within equity. When the loans get repaid, book value will accrete back up to where it stood last quarter, which is the reason we showed the reconciliation of book value and adjusted book value, assuming all the notes are repaid in full. On the second part of your question, there’s additional upside in the exit fees; those likewise flow through equity until the notes are repaid, and any exit fees are similarly accretive to book value in that same way.
Chris Muller
analystUnderstood. So perhaps going a bit further into that Palm Beach sale—the cap rate there improved quickly between July and September. I suppose, were there gains made at the property level? What exactly shifted and caused that cap rate to move up over such a short span? Do you have a set rhythm for sales that you anticipate, or is it really just opportunistic on the Koch side?
Peter Sack
executiveFor that particular asset, nothing specific at the property acted as a catalyst for improvements that would push the sale. The Koch deal required a considerable stretch of time to move from negotiation through to execution, and while that was underway, we started marketing certain of those assets where we saw a chance to sell, so that when the transaction closed, we would be positioned to carry out the portfolio changes we intended to make. The sale during the first quarter does not reflect anything new occurring in that quarter; rather, it reflects the preparatory efforts we had undertaken ahead of the Koch deal closing so we would be ready to act. As we identify chances to rotate assets out of the portfolio at an appealing cap rate and rotate assets into the portfolio at an appealing cap rate, we anticipate continuing to do so. I believe it is too soon to say what the exact rhythm will be, but we expect further opportunities to do so going forward.
Chris Muller
analystUnderstood. That's quite useful. We appreciate the two of you for fielding questions today.
Pablo Zuanic
analystThanks, and good morning to everyone. Peter, could you begin by reminding us about the steps and milestones needed for the BDC merger to close? There's the shareholders agreement, then I believe state-level approvals. Could you walk through the various remaining steps? That's the first part of the question. The second part, without getting too precise about the wording, is that it used to be I think late '26, then early '27, and today the press release just says '27. I don't know whether there have been any delays, or whether those weren't expected initially. Thank you.
Peter Sack
executiveSure. I'll have Phil address the question about merger completion steps.
Phil Silverman
executiveHi Pablo, thanks. As we’ve disclosed in public filings, LIEN submitted its initial N-14 preliminary joint proxy prospectus in July and then revised it once more in September. Right now, we’re simply moving through the standard SEC review, working cooperatively with the staff. After that review is complete, we’ll need investor approval for two things—first, the election to be treated as a BDC, and second, the merger with and into LIEN—in what amounts to a two-step shareholder voting process. That is the only public comment we can offer at this stage regarding the remaining process, other than to say it continues as usual.
Pablo Zuanic
analystAll right, thanks. Turning back to the Koch transaction, based on what you've seen since the deal closed, do you have an appetite for further deals with that kind of structure, or was this largely a one-off?
Peter Sack
executiveWe believe there are meaningful further opportunities to keep pursuing this approach of divesting properties at a lower cap rate and reinvesting into properties at a higher cap rate. Forecasting the precise cadence is hard, but that is precisely the thesis behind the Koch transaction we completed. We're glad to be able to highlight the first example of it this quarter.
Pablo Zuanic
analystAll right, just a few more points. I realize you likely can't comment much on the future combined company, but you've discussed the notion of achieving greater scale through a merger — more share, more investor interest, all of that is understood. As a means of growing over the longer term, would syndicates and agency deals form part of the strategy, or would you remain very concentrated on Chicago Atlantic origination alone? I'm just thinking in terms of purchasing books out there, mid-market books, or again, participating in syndicates when you have credit available, as a way to accelerate the scale gains for the new company.
Peter Sack
executiveAt present, our focus is on the same kinds of opportunities we have always pursued: originating transactions directly with borrowers that offer attractive risk-adjusted returns. I don't anticipate a broad move into syndicates, and I certainly don't anticipate a broad move into agency credits or mortgage-backed securities.
Pablo Zuanic
analystRight. That's all for me. Thank you.
Operator
operatorThat wraps up the Q&A portion as well as the conference. Thanks for joining today's presentation. You're free to disconnect at this time.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Chicago Atlantic Real Estate Finance, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to Chicago Atlantic Real Estate Finance, Inc. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Chicago Atlantic Real Estate Finance, Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.